Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

被引：37
|
作者：
Hagan, H
Latka, MH
Campbell, JV
Golub, ET
Garfein, RS
Thomas, DA
Kapadia, F
Strathdee, SA
机构：
[1] Natl Dev Inst, Ctr Drug Use & HIV Res, New York, NY 10010 USA
[2] Nat Res Inst, Ctr Drug Use & HIV Res, New York, NY 10010 USA
[3] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[4] Publ Hlth Seattle & King Cty, HIV AIDS Epidemiol, Seattle, WA USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] Sch Med, Baltimore, MD USA
[7] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 05期
关键词：
D O I：
10.1086/499951
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment ( e. g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
引用
收藏
页码：669 / 672
页数：4
相关论文
共 50 条
  • [31] Risk of hepatitis C virus among young adult injection drug users who share injection equipment
    Koester, S
    Heimer, R
    Barón, AE
    Glanz, J
    Teng, W
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (04) : 376 - 376
  • [32] Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
    Doab, A
    Treloar, C
    Dore, GJ
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S313 - S320
  • [33] Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
    Grebely, Jason
    Genoway, Krista A.
    Raffa, Jesse D.
    Dhadwal, Gurbir
    Rajan, Tasleem
    Showler, Grey
    Kalousek, Kate
    Duncan, Fiona
    Tyndall, Mark W.
    Fraser, Chris
    Conway, Brian
    Fischer, Benedikt
    DRUG AND ALCOHOL DEPENDENCE, 2008, 93 (1-2) : 141 - 147
  • [34] Treatment of hepatitis C virus infection in intravenous drug users
    Cowan, Matthew L.
    Maxwell, James D.
    ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
  • [35] Lack of Behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland
    Ompad, DC
    Fuller, CM
    Vlahov, D
    Thomas, D
    Strathdee, SA
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 783 - 788
  • [36] Epidemiology and natural history of hepatitis C virus infection in injection drug users: Implications for treatment
    Sulkowski, MS
    Thomas, DL
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S263 - S269
  • [37] Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users
    Backmund, M
    Meyer, K
    Edlin, BR
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1540 - 1543
  • [38] Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection
    Kuo, I
    Sherman, SG
    Thomas, DL
    Strathdee, SA
    DRUG AND ALCOHOL DEPENDENCE, 2004, 73 (01) : 69 - 78
  • [39] The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004
    Holtzman, Deborah
    Barry, Vaughn
    Ouellet, Lawrence J.
    Jarlais, Don C. Des
    Vlahov, David
    Golub, Elizabeth T.
    Hudson, Sharon M.
    Garfein, Richard S.
    PREVENTIVE MEDICINE, 2009, 49 (01) : 68 - 73
  • [40] Limited Uptake of Hepatitis C Treatment Among Injection Drug Users
    Shruti H. Mehta
    Becky L. Genberg
    Jacquie Astemborski
    Ravi Kavasery
    Gregory D. Kirk
    David Vlahov
    Steffanie A. Strathdee
    David L. Thomas
    Journal of Community Health, 2008, 33
12345